Established in 2004, YBCA plans and implements the testing of
medicines, devices and chemicals prior to their commercialisation. Our
consultancy and training services enable pharmaceutical companies to
comply with International regulations for safety, quality and
effectiveness. Such testing is required to ensure that only safe
materials are marketed.
YBCA is an integrated network with a focus on the nonclinical
and early clinical phases. Our 10 consultants, combine decades of
experience at senior management level, with the expertise to
provide cost-effective nonclinical, clinical and product safety
assessment guidance leading to product commercialisation or licensing.
We select and manage CROs and prepare
regulatory submissions, including INDs, NDAs & CTDs and collaborate
with clients to evaluate and interpret the safety of existing and